- Funding
- €12M Series A
CurifyLabs is a Helsinki-based startup that closed a €12 million Series A in July 2026. Its Compounding System Solution pairs software with GMP-manufactured excipient bases and 3D printing to automate personalised medication doses. The round funds a push into the US market — notable because most health-tech manufacturing traffic runs the other way, with American tools entering Europe.